日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.

营养物质的可用性决定了癌症代谢对非肿瘤药物的治疗反应。

Pyun Woo Yang, Park Jae Hyung, Roh Jae Won, Jeon Dongkyu, Kim Jongwan, Paik Ji Eun, Cho Seok Chan, Park So Yeon, Lim Hocheol, Kim Hyungwoo, Jang Young Jin, Lee Jaehoon, Byun Jong Hwa, Son Dong Woo, Kim Soo-Youl, Guan Kun-Liang, Lee Won Dong, Gee Heon Yung, Lee Han-Woong, No Kyoung Tai, Choi Yu Suk, Hashimoto Tadayoshi, Yoshino Takayuki, Jeong Han-Sol, Namkung Wan, Nam Joo Hyun, Park Hyun Woo

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy

来自 SCRUM-MONSTAR GOZILA 子研究的循环肿瘤 DNA 分析在晚期食管鳞状细胞癌中的预后生物标志物和免疫治疗意义

Duan, Yuqing; Hashimoto, Tadayoshi; Shibuki, Taro; Taniguchi, Hiroya; Sunakawa, Yu; Komatsu, Yoshito; Takahashi, Naoki; Sato, Yuta; Yamaguchi, Kensei; Nishina, Tomohiro; Nakanoko, Tomonori; Boku, Shogen; Satoh, Taroh; Yasui, Hisateru; Esaki, Taito; Imai, Mitsuho; Fujisawa, Takao; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki

Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)

利用液体活检多组学和人工智能 (AI) 进行分子残留病灶 (MRD) 和多癌早期检测 (MCED) 的临床开发

Shibuki, Taro; Yamashita, Riu; Hashimoto, Tadayoshi; Fujisawa, Takao; Imai, Mitsuho; Yuda, Junichiro; Kuwata, Takeshi; Misumi, Toshihiro; Nakamura, Yoshiaki; Bando, Hideaki; Kojima, Kaname; Tokioka, Sayuri; Chiba, Ippei; Nakaya, Naoki; Hozawa, Atsushi; Koshiba, Seizo; Fuse, Nobuo; Saito, Sakae; Shimizu, Ritsuko; Park, Woong-Yang; Kinoshita, Kengo; Yoshino, Takayuki

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials

人表皮生长因子受体2在接受化疗联合贝伐单抗或抗EGFR治疗的转移性结直肠癌患者中的影响:八项随机试验的探索性分析

Germani, Marco Maria; Borelli, Beatrice; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Oldani, Simone; Battaglin, Francesca; Bergamo, Francesca; Salvatore, Lisa; Stahler, Arndt; Antoniotti, Carlotta; Shitara, Kohei; Venook, Alan; Oki, Eiji; Muro, Kei; Ugolini, Clara; Soeda, Junpei; Lonardi, Sara; Pietrantonio, Filippo; Lenz, Heinz-Josef; Modest, Dominik Paul; Yoshino, Takayuki; Cremolini, Chiara

Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors

局部晚期胃食管癌和胃癌术前氟尿嘧啶、亚叶酸钙、奥沙利铂和多西他赛疗效的预后指标:整合生物标志物分析和临床病理因素

Jubashi, Amane; Nakayama, Izuma; Sakamoto, Naoya; Takei, Shogo; Matsubara, Yuki; Miyashita, Yu; Sato, Seiya; Ushiyama, Shinpei; Kobayashi, Akinori; Okazaki, Ukyo; Okemoto, Dai; Yamamoto, Kazumasa; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Yoshino, Takayuki; Kuwata, Takeshi; Sato, Kazuma; Fujita, Takeo; Yoshida, Mitsumasa; Yura, Masahiro; Kinoshita, Takahiro; Shitara, Kohei

Clinical Significance of Extrachromosomal DNA in FGFR2-Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience

FGFR2扩增型胃癌中染色体外DNA的临床意义:来自临床经验的治疗启示

Aoki, Yu; Hashimoto, Tadayoshi; Takahashi, Nobuyuki; Okunaka, Mashiro; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Nakamura, Yoshiaki; Nakayama, Izuma; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Nakamura, Nobuyuki; Sakamoto, Naoya; Ishii, Genichiro; Fujisawa, Takao; Yoshino, Takayuki; Arai, Yasuhito; Shibata, Tatsuhiro; Shitara, Kohei

Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer

曲妥珠单抗德鲁替康治疗HER2阳性胃癌或胃食管交界癌的疗效和安全性预后及预测因素

Jubashi, Amane; Nakayama, Izuma; Koganemaru, Shigehiro; Sakamoto, Naoya; Oda, Shioto; Matsubara, Yuki; Miyashita, Yu; Sato, Seiya; Ushiyama, Shinpei; Kobayashi, Akinori; Okazaki, Ukyo; Okemoto, Dai; Yamamoto, Kazumasa; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Yoshino, Takayuki; Miyaaki, Hisamitsu; Nakao, Kazuhiko; Shitara, Kohei

Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

实体瘤中 CLDN18 表达和亚型分布的景观分析:来自 MONSTAR-SCREEN-2 研究的启示

Hashimoto Tadayoshi, Iida Naoko, Nakamura Yoshiaki, Nonomura Norio, Morizane Chigusa, Iwata Hiroji, Okano Susumu, Yamagami Wataru, Yamazaki Naoya, Kadowaki Shigenori, Ueno Makoto, Boku Shogen, Oki Eiji, Komatsu Yoshito, Yuki Satoshi, Makiyama Akitaka, Ogata Takatsugu, Takahashi Naoki, Okano Naohiro, Nishina Tomohiro, Sakamoto Naoya, Kuwata Takeshi, Yamashita Riu, Shibuki Taro, Imai Mitsuho, Fujisawa Takao, Bando Hideaki, Shitara Kohei, Yoshino Takayuki

Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer

Claudin 18.2 表达对 HER2 阴性、MMR 功能正常、PD-L1 CPS ≥ 1 的转移性胃癌/胃食管交界处癌患者一线免疫化疗疗效的影响

Zhang, Fei; Nakayama, Izuma; Sakamoto, Naoya; Okemoto, Dai; Jubashi, Amane; Matsubara, Yuki; Miyashita, Yu; Sato, Seiya; Ushiyama, Shinpei; Kobayashi, Akinori; Okazaki, Ukyo; Yamamoto, Kazumasa; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Yoshino, Takayuki; Kuwata, Takeshi; Shitara, Kohei

Physical activity in older cancer patients: evidence and clinical implications

老年癌症患者的身体活动:证据和临床意义

Yajima, Shugo; Kobayashi, Shin; Hashimoto, Tadayoshi; Masuda, Hitoshi